36.92MMarket Cap-0.11P/E (TTM)
3.810High3.650Low173.30KVolume3.710Open3.750Pre Close647.17KTurnover1.79%Turnover RatioLossP/E (Static)9.74MShares28.60052wk High-6.38P/B36.67MFloat Cap3.56052wk Low--Dividend TTM9.68MShs Float3057.654Historical High--Div YieldTTM4.27%Amplitude3.560Historical Low3.734Avg Price1Lot Size
bluebird bio Stock Forum
bluebird bio has entered into a definitive agreement to be acquired by Carlyle and SK Capital in a deal valuing the company at up to $9.84 per share. Shareholders will receive $3.00 per share in cash plus a contingent value right of $6.84 per share, payable if the company achieves $600 million in net sales within a specified period ending December 31, 2027.
The transaction comes after bluebird's comprehensive strategic review involving over 70 potential investors, ...
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
Friday, 21st February at 7:30 am
bluebird stockholders to receive $3.00 per share in cash and a contingent value right of $6.84 per share in cash payable upon achievement of a net sales milestone, contingent upon offer conditions
bluebird's Board of Directors determined this transaction is in the best interest of stockholders following a comprehensive review of strategic alternatives
...
Can bluebird bio Hit $600M Sales Target? What the $9.84 Per Share Buyout Really Means
Bluebird bio Announces Definitive Agreement to Be Acquired by Carlyle and SK Capital! Bluebird bio Inc - Stockholders to Receive $3.00 per Share in Cash
Bluebird Bio: Contingent Value Right of $6.84/Share Payable Upon Achievement of Sales Milestone
The transaction is expected to close in the first half of 2025, subject to the tender of a majority of the outstandin...
No comment yet